CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
High ImpactOriginal article

CELC Stock Clocks Best Day In About 2 Months On First FDA Approval For Cancer Drug

RegulatoryapprovedPositive
AI Analysis

Summary

Celldex Therapeutics (CELC) achieved its first FDA approval for a cancer drug, resulting in the stock's best performance in approximately 2 months.

Outcome Details

First FDA approval for cancer drug

Importance:8/10
Sentiment:
0.85
FDA approvaloncologyregulatory milestonestock performance
Related Companies

Read the original article

Published by yahoo_finance on July 14, 2026 9:24 PM

Read Original